Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Suparma Tbk. (SPMA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Suparma Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Suparma Tbk. diperdagangkan di Rp172 (kapitalisasi pasar 927,49 M, volume 24 jam 1,3 jt). Perbedaan utamanya: Suparma Tbk. jauh lebih besar — sekitar 8,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SPMA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 927,49 M |
Volume | — | 1,3 jt |
Lot | — | 13,04 rb |
Perputaran | — | 222,79 jt |
Harga Rata-rata | — | 170,84 |
Nilai Transaksi | — | 222,79 jt |
Harga Ekuilibrium Indikatif | — | 172 |
Volume Ekuilibrium Indikatif | — | 102 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Suparma Tbk.
PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Selengkapnya di halaman SPMA →
